Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 8.630
Filtrer
1.
PeerJ ; 12: e17619, 2024.
Article de Anglais | MEDLINE | ID: mdl-38952980

RÉSUMÉ

Background: Andrographolide (Andro), an extract of Andrographis paniculate (Burm.f.) Wall. ex Nees (Acanthaceae), possesses diverse biologically active properties. However, the precise mechanisms and effects of Andro on pancreatic cancer (PC) remain unclear. Methods: The cytotoxic potential of Andro and underlying mechanism towards PC cells was investigated through in vitro experiments and a xenograft mouse model. PC cells were first subjected to varying concentrations of Andro. The reactive oxygen species (ROS) was assessed using flow cytometry and DCFH-DA staining. The apoptosis rate was detected by flow cytometry. Additionally, western blot was applied to evaluate the expression levels of cleaved-caspase-3, DJ-1, LC3-I, LC3-II, and p62. To further elucidate the involvement of ROS accumulation and autophagy, we employed N-acetylcysteine as a scavenger of ROS and 3-Methyladenine as an inhibitor of autophagy. Results: Andro demonstrated potent anti-proliferative effects on PC cells and induced apoptosis, both in vitro and in vivo. The cytotoxicity of Andro on PC cells was counteracted by DJ-1 overexpression. The reduction in DJ-1 expression caused by Andro led to ROS accumulation, subsequently inhibiting the growth of PC cells. Furthermore, Andro stimulated cytoprotective autophagy, thus weakening the antitumor effect. Pharmacological blockade of autophagy further enhanced the antitumor efficacy of Andro. Conclusion: Our study indicated that ROS accumulation induced by the DJ-1 reduction played a key role in Andro-mediated PC cell inhibition. Furthermore, the protective autophagy induced by the Andro in PC cells is a mechanism that needs to be addressed in future studies.


Sujet(s)
Apoptose , Autophagie , Diterpènes , Tumeurs du pancréas , Protein deglycase DJ-1 , Espèces réactives de l'oxygène , Espèces réactives de l'oxygène/métabolisme , Diterpènes/pharmacologie , Tumeurs du pancréas/traitement médicamenteux , Tumeurs du pancréas/anatomopathologie , Tumeurs du pancréas/métabolisme , Autophagie/effets des médicaments et des substances chimiques , Protein deglycase DJ-1/métabolisme , Protein deglycase DJ-1/génétique , Animaux , Humains , Souris , Lignée cellulaire tumorale , Apoptose/effets des médicaments et des substances chimiques , Tests d'activité antitumorale sur modèle de xénogreffe , Souris nude
2.
Allergol Immunopathol (Madr) ; 52(4): 91-96, 2024.
Article de Anglais | MEDLINE | ID: mdl-38970271

RÉSUMÉ

Asthma is a widely prevalent chronic disease that brings great suffering to patients and may result in death if it turns severe. Jolkinolide B (JB) is one diterpenoid component separated from the dried roots of Euphorbia fischeriana Steud (Euphorbiaceae), and has anti--inflammatory, antioxidative, and antitumor properties. However, the detailed regulatory role and associated regulatory mechanism in the progression of asthma remain elusive. In this work, it was demonstrated that the extensive infiltration of bronchial inflammatory cells and the thickening of airway wall were observed in ovalbumin (OVA)-induced mice, but these impacts were reversed by JB (10 mg/kg) treatment, indicating that JB relieved the provocative symptoms in OVA-induced asthma mice. In addition, JB can control OVA-triggered lung function and pulmonary resistance. Moreover, JB attenuated OVA-evoked inflammation by lowering the levels of interleukin (IL)-4, IL-5, and IL-13. Besides, the activated nuclear factor kappa B (NF-κB) and transforming growth factor-beta-mothers against decapentaplegic homolog 3 (TGFß/smad3) pathways in OVA-induced mice are rescued by JB treatment. In conclusion, it was disclosed that JB reduced allergic airway inflammation and airway remodeling in asthmatic mice by modulating the NF-κB and TGFß/smad3 pathways. This work could offer new opinions on JB for lessening progression of asthma.


Sujet(s)
Remodelage des voies aériennes , Asthme , Modèles animaux de maladie humaine , Diterpènes , Souris de lignée BALB C , Facteur de transcription NF-kappa B , Ovalbumine , Animaux , Asthme/traitement médicamenteux , Asthme/immunologie , Remodelage des voies aériennes/effets des médicaments et des substances chimiques , Souris , Diterpènes/pharmacologie , Diterpènes/administration et posologie , Diterpènes/usage thérapeutique , Ovalbumine/immunologie , Facteur de transcription NF-kappa B/métabolisme , Femelle , Facteur de croissance transformant bêta/métabolisme , Cytokines/métabolisme , Protéine Smad-3/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Humains , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/usage thérapeutique , Antiasthmatiques/pharmacologie , Antiasthmatiques/usage thérapeutique , Euphorbia/composition chimique
3.
Anal Cell Pathol (Amst) ; 2024: 2751280, 2024.
Article de Anglais | MEDLINE | ID: mdl-38946862

RÉSUMÉ

Background: Biliary atresia (BA) is a devastating congenital disease characterized by inflammation and progressive liver fibrosis. Activation of hepatic stellate cells (HSCs) plays a central role in the pathogenesis of hepatic fibrosis. Our study aimed to investigate the pharmacological effect and potential mechanism of pirfenidone (PFD) and andrographolide (AGP) separately and together on liver fibrosis of BA. Materials and Methods: The bile ducts of male C57BL/6J mice were ligated or had the sham operation. The in vivo effects of PFD and/or AGP on liver fibrosis of BA were evaluated. Human hepatic stellate cells (LX-2) were also treated with PFD and/or AGP in vitro. Results: PFD and/or AGP ameliorates liver fibrosis and inflammation in the mice model of BA, as evidenced by significant downregulated in the accumulation of collagen fibers, hepatic fibrosis markers (α-SMA, collagen I, and collagen IV), and inflammatory markers (IL-1ß, IL-6, and TNF-α). Moreover, compared with monotherapy, these changes are more obvious in the combined treatment of PFD and AGP. Consistent with animal experiments, hepatic fibrosis markers (α-SMA, collagen I, and CTGF) and inflammatory markers (IL-1ß, IL-6, and TNF-α) were significantly decreased in activated LX-2 cells after PFD and/or AGP treatment. In addition, PFD and/or AGP inhibited the activation of HSCs by blocking the TGF-ß/Smad signaling pathway, and the combined treatment of PFD and AGP synergistically inhibited the phosphorylation of Smad2 and Smad3. Conclusion: The combined application of PFD and AGP exerted superior inhibitive effects on HSC activation and liver fibrosis by mediating the TGF-ß/Smad signaling pathway as compared to monotherapy. Therefore, the combination of PFD and AGP may be a promising treatment strategy for liver fibrosis in BA.


Sujet(s)
Diterpènes , Cellules étoilées du foie , Cirrhose du foie , Souris de lignée C57BL , Pyridones , Transduction du signal , Protéines Smad , Facteur de croissance transformant bêta , Cellules étoilées du foie/effets des médicaments et des substances chimiques , Cellules étoilées du foie/métabolisme , Cellules étoilées du foie/anatomopathologie , Animaux , Cirrhose du foie/anatomopathologie , Cirrhose du foie/traitement médicamenteux , Cirrhose du foie/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Diterpènes/pharmacologie , Diterpènes/usage thérapeutique , Mâle , Facteur de croissance transformant bêta/métabolisme , Protéines Smad/métabolisme , Humains , Pyridones/pharmacologie , Lignée cellulaire , Souris , Atrésie des voies biliaires/anatomopathologie , Atrésie des voies biliaires/traitement médicamenteux , Atrésie des voies biliaires/métabolisme , Modèles animaux de maladie humaine , Association de médicaments
4.
Int J Mol Sci ; 25(12)2024 Jun 13.
Article de Anglais | MEDLINE | ID: mdl-38928225

RÉSUMÉ

Acute myeloid leukemia (AML) is an aggressive blood cancer. With low survival rates, new drug targets are needed to improve treatment regimens and patient outcomes. Pseudolaric acid B (PAB) is a plant-derived bioactive compound predicted to interact with cluster of differentiation 147 (CD147/BSG). CD147 is a transmembrane glycoprotein overexpressed in various malignancies with suggested roles in regulating cancer cell survival, proliferation, invasion, and apoptosis. However, the detailed function of PAB in AML remains unknown. In this study, AML cell lines and patient-derived cells were used to show that PAB selectively targeted AML (IC50: 1.59 ± 0.47 µM). Moreover, proliferation assays, flow cytometry, and immunoblotting confirmed that PAB targeting of CD147 resulted in AML cell apoptosis. Indeed, the genetic silencing of CD147 significantly suppressed AML cell growth and attenuated PAB activity. Overall, PAB imparts anti-AML activity through transmembrane glycoprotein CD147.


Sujet(s)
Apoptose , Antigènes CD147 , Prolifération cellulaire , Diterpènes , Leucémie aigüe myéloïde , Humains , Antigènes CD147/métabolisme , Antigènes CD147/génétique , Leucémie aigüe myéloïde/traitement médicamenteux , Leucémie aigüe myéloïde/métabolisme , Leucémie aigüe myéloïde/anatomopathologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Diterpènes/pharmacologie , Survie cellulaire/effets des médicaments et des substances chimiques
5.
Sci Rep ; 14(1): 14674, 2024 06 25.
Article de Anglais | MEDLINE | ID: mdl-38918539

RÉSUMÉ

Sphaeropsidins are iso-pimarane diterpenes produced by phytopathogenic fungi that display promising anticancer activities. Sphaeropsidin A, in particular, has been shown to counteract regulatory volume increase, a process used by cancer cells to avoid apoptosis. This study reports the hemi-synthesis of new lipophilic derivatives obtained by modifications of the C15,C16-alkene moiety. Several of these compounds triggered severe ER swelling associated with strong proteasomal inhibition and consequently cell death, a feature that was not observed with respect to mode of action of the natural product. Significantly, an analysis from the National Cancer Institute sixty cell line testing did not reveal any correlations between the most potent derivative and any other compound in the database, except at high concentrations (LC50). This study led to the discovery of a new set of sphaeropsidin derivatives that may be exploited as potential anti-cancer agents, notably due to their maintained activity towards multidrug resistant models.


Sujet(s)
Réticulum endoplasmique , Humains , Réticulum endoplasmique/effets des médicaments et des substances chimiques , Réticulum endoplasmique/métabolisme , Lignée cellulaire tumorale , Apoptose/effets des médicaments et des substances chimiques , Antinéoplasiques/pharmacologie , Antinéoplasiques/composition chimique , Diterpènes/pharmacologie , Diterpènes/composition chimique , Abiétanes/pharmacologie , Abiétanes/composition chimique
6.
Front Immunol ; 15: 1380229, 2024.
Article de Anglais | MEDLINE | ID: mdl-38911867

RÉSUMÉ

Background: Vitamin E, which is also known as tocopherol, is a compound with a polyphenol structure. Its esterified derivative, Vitamin E succinate (VES), exhibits unique anticancer and healthcare functions as well as immunomodulatory effects. Natural polysaccharides are proved to be a promising material for nano-drug delivery systems, which show excellent biodegradability and biocompatibility. In this study, we employed a novel bletilla striata polysaccharide-vitamin E succinate polymer (BSP-VES) micelles to enhance the tumor targeting and anti-colon cancer effect of andrographolide (AG). Methods: BSP-VES polymer was synthesized through esterification and its structure was confirmed using 1H NMR. AG@BSP-VES was prepared via the dialysis method and the drug loading, entrapment efficiency, stability, and safety were assessed. Furthermore, the tumor targeting ability of AG@BSP-VES was evaluated through targeted cell uptake and in vivo imaging. The antitumor activity of AG@BSP-VES was measured in vitro using MTT assay, Live&Dead cell staining, and cell scratch test. Results: In this study, we successfully loaded AG into BSP-VES micelles (AG@BSP-VES), which exhibited good stability, biosafety and sustained release effect. In addition, AG@BSP-VES also showed excellent internalization capability into CT26 cells compared with NCM460 cells in vitro. Meanwhile, the specific delivery of AG@BSP-VES micelles into subcutaneous and in-situ colon tumors was observed compared with normal colon tissues in vivo during the whole experiment process (1-24 h). What's more, AG@BSP-VES micelles exhibited significant antitumor activities than BSP-VES micelles and free AG. Conclusion: The study provides a meaningful new idea and method for application in drug delivery system and targeted treatment of colon cancer based on natural polysaccharides.


Sujet(s)
Tumeurs du côlon , Diterpènes , Micelles , Polyosides , Animaux , Tumeurs du côlon/traitement médicamenteux , Diterpènes/composition chimique , Diterpènes/pharmacologie , Diterpènes/administration et posologie , Humains , Souris , Lignée cellulaire tumorale , Polyosides/composition chimique , Antinéoplasiques/pharmacologie , Antinéoplasiques/administration et posologie , Antinéoplasiques/composition chimique , Systèmes de délivrance de médicaments , Tests d'activité antitumorale sur modèle de xénogreffe , Vecteurs de médicaments/composition chimique , Nanoparticules/composition chimique , Système d'administration de médicaments à base de nanoparticules/composition chimique , Souris nude , Souris de lignée BALB C
7.
Cells ; 13(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38891113

RÉSUMÉ

Tigilanol tiglate (TT, also known as EBC-46) is a novel, plant-derived diterpene ester possessing anticancer and wound-healing properties. Here, we show that TT-evoked PKC-dependent S985 phosphorylation of the tyrosine kinase MET leads to subsequent degradation of tyrosine phosphorylated p-Y1003 and p-Y1234/5 MET species. PKC inhibition with BIM-1 blocked S985 phosphorylation of MET and led to MET cell surface accumulation. Treatment with metalloproteinase inhibitors prevented MET-ECD release into cell culture media, which was also blocked by PKC inhibitors. Furthermore, unbiased secretome analysis, performed using TMT-technology, identified additional targets of TT-dependent release of cell surface proteins from H357 head and neck cancer cells. We confirm that the MET co-signalling receptor syndecan-1 was cleaved from the cell surface in response to TT treatment. This was accompanied by rapid cleavage of the cellular junction adhesion protein Nectin-1 and the nerve growth factor receptor NGFRp75/TNFR16. These findings, that TT is a novel negative regulator of protumorigenic c-MET and NGFRp75/TNFR16 signalling, as well as regulating Nectin-1-mediated cell adhesion, further contribute to our understanding of the mode of action and efficacy of TT in the treatment of solid tumours.


Sujet(s)
Tumeurs de la tête et du cou , Protéines proto-oncogènes c-met , Humains , Protéines proto-oncogènes c-met/métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Tumeurs de la tête et du cou/métabolisme , Tumeurs de la tête et du cou/anatomopathologie , Tumeurs de la tête et du cou/traitement médicamenteux , Tumeurs de la tête et du cou/génétique , Lignée cellulaire tumorale , Sécrétome/métabolisme , Diterpènes/pharmacologie , Protéines membranaires/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Syndécane-1/métabolisme , Nectines/métabolisme , Protéine kinase C/métabolisme
8.
Int J Mol Sci ; 25(11)2024 May 31.
Article de Anglais | MEDLINE | ID: mdl-38892285

RÉSUMÉ

The diterpene cafestol represents the most potent cholesterol-elevating compound known in the human diet, being responsible for more than 80% of the effect of coffee on serum lipids, with a mechanism still not fully clarified. In the present study, the interaction of cafestol and 16-O-methylcafestol with the stabilized ligand-binding domain (LBD) of the Farnesoid X Receptor was evaluated by fluorescence and circular dichroism. Fluorescence quenching was observed with both cafestol and 16-O-methylcafestol due to an interaction occurring in the close environment of the tryptophan W454 residue of the protein, as confirmed by docking and molecular dynamics. A conformational change of the protein was also observed by circular dichroism, particularly for cafestol. These results provide evidence at the molecular level of the interactions of FXR with the coffee diterpenes, confirming that cafestol can act as an agonist of FXR, causing an enhancement of the cholesterol level in blood serum.


Sujet(s)
Cholestérol , Café , Diterpènes , Récepteurs cytoplasmiques et nucléaires , Diterpènes/pharmacologie , Diterpènes/composition chimique , Récepteurs cytoplasmiques et nucléaires/métabolisme , Récepteurs cytoplasmiques et nucléaires/agonistes , Cholestérol/métabolisme , Humains , Café/composition chimique , Simulation de docking moléculaire , Liaison aux protéines , Simulation de dynamique moléculaire , Dichroïsme circulaire
9.
Drug Deliv ; 31(1): 2354687, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-38823413

RÉSUMÉ

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death worldwide. Beside early detection, early diagnosis, and early surgery, it is urgent to try new strategies for the treatment of HCC. Triptolide (TPL) has been employed to treat HCC. However, its clinical applications were restricted by the narrow therapeutic window, severe toxicity, and poor water-solubility. In this study, we developed cancer cell membrane-camouflaged biomimetic PLGA nanoparticles loading TPL (TPL@mPLGA) with the homologous targeting property for the treatment of HCC. The TPL@mPLGA was successfully prepared with particle size of 195.5 ± 7.5 nm and zeta potential at -21.5 ± 0.2 mV with good stability. The drug loading (DL) of TPL@mPLGA was 2.94%. After Huh-7 cell membrane coating, the natural Huh-7 cell membrane proteins were found to be retained on TPL@mPLGA, thus endowing the TPL@mPLGA with enhanced accumulation at tumor site, and better anti-tumor activity in vitro and in vivo when compared with TPL or TPL@PLGA. The TPL@mPLGA showed enhanced anti-tumor effects and reduced toxicity of TPL, which could be adopted for the treatment of HCC.


Sujet(s)
Carcinome hépatocellulaire , Diterpènes , Composés époxy , Tumeurs du foie , Nanoparticules , Phénanthrènes , Copolymère d'acide poly(lactique-co-glycolique) , Diterpènes/administration et posologie , Diterpènes/pharmacologie , Diterpènes/composition chimique , Diterpènes/pharmacocinétique , Carcinome hépatocellulaire/traitement médicamenteux , Carcinome hépatocellulaire/anatomopathologie , Composés époxy/composition chimique , Composés époxy/administration et posologie , Composés époxy/pharmacologie , Phénanthrènes/administration et posologie , Phénanthrènes/pharmacologie , Phénanthrènes/composition chimique , Phénanthrènes/pharmacocinétique , Tumeurs du foie/traitement médicamenteux , Tumeurs du foie/anatomopathologie , Humains , Copolymère d'acide poly(lactique-co-glycolique)/composition chimique , Nanoparticules/composition chimique , Animaux , Lignée cellulaire tumorale , Souris , Membrane cellulaire/effets des médicaments et des substances chimiques , Taille de particule , Vecteurs de médicaments/composition chimique , Souris nude , Matériaux biomimétiques/composition chimique , Matériaux biomimétiques/pharmacologie , Souris de lignée BALB C
10.
Biomed Pharmacother ; 176: 116939, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38870629

RÉSUMÉ

BACKGROUND: Sclareol (SCL), a labdane diterpene compound found in Salvia sclarea L., exhibited therapeutic effects. This study investigated the potential interaction between SCL and diazepam (DZP) in modulating sedation in the thiopental sodium-induced sleeping animal model, supported by in-silico molecular docking analysis. METHODS: The control, sclareol (5, 10 and 20 mg/kg), and the reference drugs [diazepam: 3 mg/kg and Caffeine (CAF): 10 mg/kg] were used in male albino mice. Then, sodium thiopental (40 mg/kg, i.p.) was administrated to induce sleep. The latent period, percentage of sleep incidence and modulation of latency were measured. Further, homology modeling of human γ-aminobutyric acid (GABA) was conducted examine the binding mode of GABA interaction with SCL, DZP, and CAF compounds RESULTS: SCL (low dose) slightly increased the sleep latency, while the higher dose significantly prolonged sleep latency. DZP, a GABAA receptor agonist, exhibited strong sleep-inducing properties, reducing sleep latency, and increasing sleeping time. Caffeine (CAF) administration prolonged sleep latency and reduced sleeping time, consistent with its stimulant effects. The combination treatments involving SCL, DZP, and CAF showed mixed effects on sleep parameters. The molecular docking revealed good binding affinities of SCL, DZP, and CAF for GABAA receptor subunits A2 and A5. CONCLUSIONS: Our findings highlighted the complex interplay between SCL, DZP, and CAF in regulating sleep behaviors and provided insights into potential combination therapies for sleep disorders.


Sujet(s)
Diazépam , Hypnotiques et sédatifs , Simulation de docking moléculaire , Sommeil , Thiopental , Animaux , Mâle , Hypnotiques et sédatifs/pharmacologie , Souris , Diazépam/pharmacologie , Sommeil/effets des médicaments et des substances chimiques , Thiopental/pharmacologie , Diterpènes/pharmacologie , Caféine/pharmacologie , Simulation numérique , Récepteurs GABA-A/métabolisme , Humains , Relation dose-effet des médicaments , Latence d'endormissement/effets des médicaments et des substances chimiques
11.
Exp Biol Med (Maywood) ; 249: 10051, 2024.
Article de Anglais | MEDLINE | ID: mdl-38881848

RÉSUMÉ

Podocyte injury or dysfunction can lead to proteinuria and glomerulosclerosis. Zonula occludens 1 (ZO-1) is a tight junction protein which connects slit diaphragm (SD) proteins to the actin cytoskeleton. Previous studies have shown that the expression of ZO-1 is decreased in chronic kidney disease (CKD). Thus, elucidation of the regulation mechanism of ZO-1 has considerable clinical importance. Triptolide (TP) has been reported to exert a strong antiproteinuric effect by inhibiting podocyte epithelial mesenchymal transition (EMT) and inflammatory response. However, the underlying mechanisms are still unclear. We found that TP upregulates ZO-1 expression and increases the fluorescence intensity of ZO-1 in a puromycin aminonucleoside (PAN)-induced podocyte injury model. Permeablity assay showed TP decreases podocyte permeability in PAN-treated podocyte. TP also upregulates the DNA demethylase TET2. Our results showed that treatment with the DNA methyltransferase inhibitors 5-azacytidine (5-AzaC) and RG108 significantly increased ZO-1 expression in PAN-treated podocytes. Methylated DNA immunoprecipitation (MeDIP) and hydroxymethylated DNA immunoprecipitation (hMeDIP) results showed that TP regulates the methylation status of the ZO-1 promoter. Knockdown of TET2 decreased ZO-1 expression and increased methylation of its promoter, resulting in the increase of podocyte permeability. Altogether, these results indicate that TP upregulates the expression of ZO-1 and decreases podocyte permeability through TET2-mediated 5 mC demethylation. These findings suggest that TP may alleviate podocyte permeability through TET2-mediated hydroxymethylation of ZO-1.


Sujet(s)
Dioxygenases , Diterpènes , Composés époxy , Phénanthrènes , Podocytes , Protéine-1 de la zonula occludens , Podocytes/métabolisme , Podocytes/effets des médicaments et des substances chimiques , Podocytes/anatomopathologie , Protéine-1 de la zonula occludens/métabolisme , Phénanthrènes/pharmacologie , Diterpènes/pharmacologie , Composés époxy/pharmacologie , Dioxygenases/métabolisme , Animaux , Protéines de liaison à l'ADN/métabolisme , Souris , Protéines proto-oncogènes/métabolisme , Perméabilité/effets des médicaments et des substances chimiques , Humains , Méthylation de l'ADN/effets des médicaments et des substances chimiques
12.
Molecules ; 29(11)2024 May 24.
Article de Anglais | MEDLINE | ID: mdl-38893370

RÉSUMÉ

Kallopterolides A-I (1-9), a family of nine diterpenoids possessing either a cleaved pseudopterane or a severed cembrane skeleton, along with several known compounds were isolated from the Caribbean Sea plume Antillogorgia kallos. The structures and relative configurations of 1-9 were characterized by analysis of HR-MS, IR, UV, and NMR spectroscopic data in addition to computational methods and side-by-side comparisons with published NMR data of related congeners. An investigation was conducted as to the potential of the kallopterolides as plausible in vitro anti-inflammatory, antiprotozoal, and antituberculosis agents.


Sujet(s)
Anthozoa , Diterpènes , Diterpènes/composition chimique , Diterpènes/isolement et purification , Diterpènes/pharmacologie , Animaux , Anthozoa/composition chimique , Antiprotozoaires/composition chimique , Antiprotozoaires/pharmacologie , Antiprotozoaires/isolement et purification , Caraïbe , Structure moléculaire , Anti-inflammatoires/composition chimique , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/isolement et purification , Spectroscopie par résonance magnétique , Antituberculeux/composition chimique , Antituberculeux/pharmacologie , Antituberculeux/isolement et purification
13.
Molecules ; 29(11)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38893484

RÉSUMÉ

To better assess the practical value and avoid potential risks of the traditionally medicinal and edible basidiomycete Schizophyllum commune, which may arise from undescribed metabolites, a combination of elicitors was introduced for the first time to discover products from cryptic and low-expressed gene clusters under laboratory cultivation. Treating S. commune NJFU21 with the combination of five elicitors led to the upregulated production of a class of unusual linear diterpene-derived variants, including eleven new ones (1-11), along with three known ones (12-14). The structures and stereochemistry were determined by 1D and 2D NMR, HRESIMS, ECD, OR and VCD calculations. Notably, the elongation terminus of all the diterpenes was decorated by an unusual butenedioic acid moiety. Compound 1 was a rare monocyclic diterpene, while 2-6 possessed a tetrahydrofuran moiety. The truncated metabolites 4, 5 and 13 belong to the trinorditerpenes. All the diterpenes displayed approximately 70% scavenging of hydroxyl radicals at 50 µM and null cytotoxic activity at 10 µM. In addition, compound 1 exhibited potent antifungal activity against the plant pathogenic fungi Colletotrichum camelliae, with MIC values of 8 µg/mL. Our findings indicated that this class of diterpenes could provide valuable protectants for cosmetic ingredients and the lead compounds for agricultural fungicide development.


Sujet(s)
Diterpènes , Schizophyllum , Diterpènes/pharmacologie , Diterpènes/composition chimique , Diterpènes/métabolisme , Schizophyllum/métabolisme , Schizophyllum/génétique , Structure moléculaire , Régulation positive/effets des médicaments et des substances chimiques , Humains
14.
Cell Mol Biol (Noisy-le-grand) ; 70(6): 192-198, 2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38836662

RÉSUMÉ

Intervertebral disc degeneration (IDD) is characterized by the decreased function and number of nucleus pulposus cells (NPCs) caused by excessive intervertebral disc (IVD) pressure. This research aims to provide novel insights into IDD prevention and treatment by clarifying the effect of andrographolide (ANDR) on IDD cell autophagy and oxidative stress under mechanical stress. Human primary NPCs were extracted from the nucleus pulposus tissue of non-IDD trauma patients. An IDD cell model was established by posing mechanical traction on NPCs. Through the construction of an IDD rat model, the influence of ANDR on IDD pathological changes was explored in vivo. The proliferation and autophagy of NPCs were decreased while the apoptosis rate and oxidative stress reaction were increased by mechanical traction. ANDR intervention obviously alleviated this situation. MiR-9 showed upregulated expression in IDD cell model, while FoxO3 and PINK1/Parkin were downregulated. Decreased proliferation and autophagy as well as enhanced apoptosis and oxidative stress response of NPCs were observed following miR-9 mimics and H89 intervention, while the opposite trend was observed after FoxO3 overexpression. FoxO3 is a direct target downstream miR-9. The in vivo experiments revealed that after ANDR intervention, the number of apoptotic cells in rat IVD tissue decreased and the autophagy increased. In conclusion, ANDR improves NPC proliferation, and autophagy, inhibits apoptosis and oxidative stress, and alleviates the pathological changes of IDD via the miR-9/FoxO3/PINK1/Parkin axis, which may be a new and effective treatment for IDD in the future.


Sujet(s)
Autophagie , Diterpènes , Protéine O3 à motif en tête de fourche , Dégénérescence de disque intervertébral , microARN , Nucleus pulposus , Stress oxydatif , Protein kinases , Rat Sprague-Dawley , Contrainte mécanique , Ubiquitin-protein ligases , microARN/métabolisme , microARN/génétique , Autophagie/effets des médicaments et des substances chimiques , Protéine O3 à motif en tête de fourche/métabolisme , Protéine O3 à motif en tête de fourche/génétique , Stress oxydatif/effets des médicaments et des substances chimiques , Animaux , Dégénérescence de disque intervertébral/métabolisme , Dégénérescence de disque intervertébral/anatomopathologie , Humains , Diterpènes/pharmacologie , Nucleus pulposus/métabolisme , Nucleus pulposus/effets des médicaments et des substances chimiques , Ubiquitin-protein ligases/métabolisme , Ubiquitin-protein ligases/génétique , Protein kinases/métabolisme , Protein kinases/génétique , Rats , Mâle , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Femelle , Adulte , Modèles animaux de maladie humaine
15.
Phytomedicine ; 131: 155796, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38852475

RÉSUMÉ

BACKGROUND AND PURPOSE: Leishmaniasis is a globally prevalent vector-borne disease caused by parasites of the genus Leishmania. The available chemotherapeutic drugs present problems related to efficacy, emergence of parasite resistance, toxicity and high cost, justifying the search for new drugs. Several classes of compounds have demonstrated activity against Leishmania, including icetexane-type diterpenes, previously isolated from Salvia and other Lamiaceae genera. Thus, in this study, compounds of Salvia procurrens were investigated for their leishmanicidal and immunomodulatory activities. METHODS: The exudate of S. procurrens was obtained by rapidly dipping the aerial parts in dichloromethane. The compounds were isolated by column and centrifugal planar chromatography over silica gel. The effects on L. amazonensis growth, survival, membrane integrity, reactive oxygen species (ROS) generation, mitochondrial membrane potential and cytotoxicity of the compounds towards human erythrocytes, peripheral blood mononuclear cells and macrophages were evaluated. The effects on intracellular amastigote forms, nitric oxide (NO) and TNF-α production were also investigated. RESULTS: The exudate from the leaves afforded the novel icetexane 7-hydroxyfruticulin A (1) as well as the known demethylisofruticulin A (2), fruticulin A (3) and demethylfruticulin A (4). The compounds (1-4) were tested against promastigotes of L. amazonensis and showed an effective inhibition of the parasite survival (IC50 = 4.08-16.26 µM). In addition, they also induced mitochondrial ROS production, plasma membrane permeability and mitochondrial dysfunction in treated parasites, and presented low cytotoxicity against macrophages. Furthermore, all diterpenes tested reduced the number of parasites inside macrophages, by mechanisms involving TNF-α, NO and ROS. CONCLUSION: The results suggest the potential of 7-hydroxyfruticulin A (1) as well as the known demethylisofruticulin A (2),fruticulin A (3) and demethylfruticulin A (4) as candidates for use in further studies on the design of anti-leishmanial drugs.


Sujet(s)
Leishmania , Monoxyde d'azote , Espèces réactives de l'oxygène , Salvia , Facteur de nécrose tumorale alpha , Salvia/composition chimique , Espèces réactives de l'oxygène/métabolisme , Humains , Leishmania/effets des médicaments et des substances chimiques , Animaux , Facteur de nécrose tumorale alpha/métabolisme , Monoxyde d'azote/métabolisme , Souris , Macrophages/effets des médicaments et des substances chimiques , Antiprotozoaires/pharmacologie , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Feuilles de plante/composition chimique , Diterpènes/pharmacologie , Diterpènes/composition chimique , Agranulocytes/effets des médicaments et des substances chimiques , Érythrocytes/effets des médicaments et des substances chimiques , Érythrocytes/parasitologie , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Souris de lignée BALB C , Cellules RAW 264.7
16.
Antivir Ther ; 29(3): 13596535241259952, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38873947

RÉSUMÉ

Angiotensin-converting enzyme 2 (ACE2) is the receptor that enables SARS-CoV-2 to invade host cells. Previous studies have reported that reducing ACE2 expression may have an anti-SARS-CoV-2 effect. In this study, we constructed a pGL4.10-F2-ACE2 vector with double luciferase genes (firefly and Renilla luciferase) under the control of the ACE2 promoter and used it to screen compounds from Chinese traditional medicinal herbs (CTMHs) that can inhibit ACE2 transcription in human cells. We transfected HEK293T cells with pGL4.10-F2-ACE2 and treated them with CTMH compounds and then measured fluorescence to evaluate the indirect inhibition of ACE2 transcription. Out of 37 compounds tested, andrographolide demonstrated a dose-dependent inhibition of ACE2 transcription. We further confirmed by RT-qPCR and Western blot assays that andrographolide also reduced ACE2 expression in BEAS-2B cells in a dose-dependent manner. Moreover, pseudovirus infection assays in BEAS-2B cells demonstrated that andrographolide can inhibit SARS-CoV-2 infection in a dose-dependent manner. These results suggest that andrographolide has potential anti-SARS-CoV-2 activity and could be a candidate drug for COVID-19 prevention and treatment.


Sujet(s)
Angiotensin-converting enzyme 2 , Traitements médicamenteux de la COVID-19 , Diterpènes , Régulation négative , SARS-CoV-2 , Humains , Diterpènes/pharmacologie , Angiotensin-converting enzyme 2/génétique , Angiotensin-converting enzyme 2/métabolisme , SARS-CoV-2/effets des médicaments et des substances chimiques , SARS-CoV-2/génétique , Cellules HEK293 , Régulation négative/effets des médicaments et des substances chimiques , COVID-19/virologie , Antiviraux/pharmacologie , Médicaments issus de plantes chinoises/pharmacologie
17.
Sci Rep ; 14(1): 13967, 2024 06 17.
Article de Anglais | MEDLINE | ID: mdl-38886585

RÉSUMÉ

Twelve polyoxygenated cyclohex(a/e)ne diterpene esters, named albiflorenes A-L (1-12), were isolated from the whole plants of Kaempferia albiflora, known as "Prao Mang Mum." Their structures and relative stereochemistry were determined by extensive spectroscopic analysis. Furthermore, the comparison of experimental electronic circular dichroism (ECD) curves with the curves predicted by TDDFT was used to determine the absolute configurations. Albiflorenes contain polyoxygenated cyclohexane (or cyclohexene) derivatives, which are linked to either isopimarane or abietane diterpene acid units. The discovery marks the first occurrence of a conjugate between polyoxygenated cyclohexane (or cyclohexene) rings and diterpenoids. Among the isolates, albiflorene C specifically exhibited antibacterial activity against Bacillus cereus with MIC and MBC values of 3.13 and 6.25 µg/mL, respectively.


Sujet(s)
Antibactériens , Diterpènes , Esters , Tests de sensibilité microbienne , Zingiberaceae , Diterpènes/composition chimique , Diterpènes/pharmacologie , Diterpènes/isolement et purification , Esters/composition chimique , Esters/pharmacologie , Zingiberaceae/composition chimique , Antibactériens/pharmacologie , Antibactériens/composition chimique , Antibactériens/isolement et purification , Bacillus cereus/effets des médicaments et des substances chimiques , Structure moléculaire , Dichroïsme circulaire
18.
Immun Inflamm Dis ; 12(6): e1322, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38888462

RÉSUMÉ

INTRODUCTION: Triptolide (TP), a natural product derived from the herbal medicine Tripterygium wilfordii, exhibits potent immunosuppressive activity. However, the mechanisms underlying its effects in rheumatoid arthritis remain incompletely understood. METHODS: Collagen-induced arthritis (CIA) model was induced in Sprague-Dawley rats by immunization with bovine type II collagen, and TP was administrated as treatment. The therapeutic effect of TP was evaluated based on paw swelling, histopathology, and serum levels of inflammatory factors. Exosomes isolated from rat serum were characterized by transmission electron microscopy, dynamic light scattering, and western blot analysis. Proteomic profiling of exosomes was analyzed by direct DIA quantitative proteomics analysis. Gene ontology and the Kyoto Encyclopedia of Genes and Genomes databases were employed for enrichment analysis related to molecular function, biological processes, and signaling pathways. Western blot analysis was used to analyze differentially expressed proteins. RESULTS: TP treatment ameliorated arthritic phenotypes in CIA rats as evidenced by reduced arthritis score, paw swelling, pathological injury severity scores, and serum levels of inflammatory cytokines. The proteomic analysis revealed that TP treatment significantly inhibited complement and coagulation cascades, interleukin-17 signaling pathway, and cholesterol metabolism, which were reactivated in CIA rats. Importantly, lipocalin 2 (LCN2) and myeloperoxidase (MPO) levels were markedly upregulated in the CIA group but suppressed upon TP administration. Furthermore, in synovial tissues, LCN2 and MPO expression levels were also elevated in the CIA group but decreased following TP treatment. CONCLUSION: Our findings demonstrate that TP alleviates CIA, possibly through modulation of exosomal LCN2 and MPO proteins.


Sujet(s)
Arthrite expérimentale , Diterpènes , Composés époxy , Exosomes , Phénanthrènes , Protéomique , Rat Sprague-Dawley , Animaux , Composés époxy/pharmacologie , Composés époxy/usage thérapeutique , Phénanthrènes/pharmacologie , Phénanthrènes/usage thérapeutique , Diterpènes/pharmacologie , Diterpènes/usage thérapeutique , Arthrite expérimentale/traitement médicamenteux , Arthrite expérimentale/métabolisme , Arthrite expérimentale/immunologie , Rats , Protéomique/méthodes , Exosomes/métabolisme , Mâle , Polyarthrite rhumatoïde/traitement médicamenteux , Polyarthrite rhumatoïde/immunologie , Polyarthrite rhumatoïde/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine
19.
Int J Mol Sci ; 25(12)2024 Jun 18.
Article de Anglais | MEDLINE | ID: mdl-38928398

RÉSUMÉ

Five new diterpenes including four diterpenes with 1,2,3,4,4a,5,6,8a-octalin skeleton talaroacids A-D (1-4) and an isopimarane diterpenoid talaromarane A (5) were isolated from the mangrove endophytic fungus Talaromyces sp. JNQQJ-4. Their structures and absolute configurations were determined by analysis of high-resolution electrospray ionization mass spectroscopy (HRESIMS), 1D/2D Nuclear Magnetic Resonance (NMR) spectra, single-crystal X-ray diffraction, quantum chemical calculation, and electronic circular dichroism (ECD). Talaromarane A (5) contains a rare 2-oxabicyclo [3.2.1] octan moiety in isopimarane diterpenoids. In bioassays, compounds 1, 2, 4, and 5 displayed significant anti-inflammatory activities with the IC50 value from 4.59 to 21.60 µM.


Sujet(s)
Anti-inflammatoires , Diterpènes , Talaromyces , Talaromyces/composition chimique , Diterpènes/pharmacologie , Diterpènes/composition chimique , Diterpènes/isolement et purification , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/composition chimique , Anti-inflammatoires/isolement et purification , Animaux , Souris , Structure moléculaire , Cellules RAW 264.7 , Spectroscopie par résonance magnétique
20.
Molecules ; 29(12)2024 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-38930799

RÉSUMÉ

Four new diterpenoids, isodosins A-D (1-4), together with nine known compounds (5-13) were isolated and identified from the aerial parts of Isodon serra (Maxim.) Hara. The structures of the new diterpenoids were elucidated based on the analysis of HR-ESI-MS data, 1D/2D-NMR-spectroscopic data, and electronic circular dichroism (ECD) calculations. Cytotoxicities of compounds 2, 3, 5, 6, and 9 against the HepG2 and H1975 cell lines were evaluated with the MTT assay. As a result, compounds 2, 3, and 6 revealed higher levels of cytotoxicity against HepG2 cells than against H1975 cells. Moreover, compund 6 demonstrated the most efficacy in inhibiting the proliferation of HepG2 cells, with an IC50 value of 41.13 ± 3.49 µM. This effect was achieved by inducing apoptosis in a dose-dependent manner. Furthermore, the relationships between the structures and activities of these compounds are briefly discussed.


Sujet(s)
Antinéoplasiques d'origine végétale , Apoptose , Diterpènes , Isodon , Parties aériennes de plante , Humains , Diterpènes/composition chimique , Diterpènes/pharmacologie , Diterpènes/isolement et purification , Isodon/composition chimique , Parties aériennes de plante/composition chimique , Antinéoplasiques d'origine végétale/pharmacologie , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Apoptose/effets des médicaments et des substances chimiques , Cellules HepG2 , Structure moléculaire , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Extraits de plantes/composition chimique , Extraits de plantes/pharmacologie , Relation structure-activité , Survie cellulaire/effets des médicaments et des substances chimiques , Tests de criblage d'agents antitumoraux
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...